Welcome to Bursa Malaysia/KLSE Research Summary

Welcome to Bursa Malaysia/KLSE Research Summary
Showing posts with label Vitrox. Show all posts
Showing posts with label Vitrox. Show all posts

Monday, November 24, 2014

HLIB Research Summary - 24 Nov 2014

Lafarge (BUY é)
3Q14 Analyst Briefing
  • Disappointing 3QFY14 performance. To recap, Lafarge’s 3QFY14 net profit declined due to higher input cost and pricing pressure from the market arising from Lafarge’s stance to regain and reposition itself as the market leader.
  • Mitigating higher electricity and fuel costs via efficiency. Energy and fuel costs now consist of 50% of total cost and the only strategy to mitigate the rising price of electricity and fuel is by being more efficient.
  • Coal prices for FY15. The company recently finalised the terms for the supply of coal for next year and has hinted that the prices for next year is marginally lower compared to FY14.
  • Outlook for 2015. Price volatility is expected to continue and industry cement demand will continue to sustain into next year, with a projected mid-single digit demand growth of 3-5% in 2015, similar pace for 2014.
  • We slashed FY14 by 6.1% to impute the weak 9MFY14 results. However, we have revised upwards our FY15-FY16 earnings by 7.4% and 11.6% due to (1) lower coal price; and (2) higher domestic net selling prices.
  • Despite the disappointing 3QFY14, our TP is raised to RM10.72 based on 22.5x 2016 EPS of 47.7 sen. We have raised our P/E on the stock to 22.5x, one standard deviation above its 1-year forward average P/E of the last 3 years.  We upgrade our rating from Hold to BUY.
Star Publications (BUY é)
A sweet dividend for the ride
  • We attended Star’s 9MFY14 briefing, chaired by its Managing Director/CEO, Datuk Seri Wong Chun Wai and the management team.
  • A pretty good cost management… Star will continue to keep its costs well controlled. Will also benefit from low newsprint prices which have been on a downtrend (see Figure #1).
  • Appealing dividends… It is likely to retain the dividend payment of 15 – 18 sen/share, translating to a dividend yield of 6.6% - 7.9%.
  • FY14, FY15 and FY16 earnings trimmed by 1%-3%, as we assume weaker macro environment which contributes to a poorer consumer and business sentiment.
  • Despite the soft adex environment, we see better prospect for Star based on their prudent cost management, strong balance sheet with net cash position and attractive dividend yield. Also, its share price has, since the beginning of November, declined by 12%. Thus, we upgrade Star to a BUY call, TP revised upwards by 7% to RM2.73 based on an unchanged dividend yield of 5.5% as we increase our dividend forecasts from 14.0 to 15.0 sen/share. 
ViTrox (BUY çè)
Deliver as Promised
  • Again, achieved new highs in revenue and profit merely with 9 months results. FY14 top line is forecasted grow 55.7% yoy reaching ~RM165m.
  • MVS-S: resilient 3Q14 order despite seasonality weakness. 4Q14 revenue is forecasted to be ranging RM9-10m. Demand is expected to pick up from 2Q15 onwards.
  • MVS-T: YTD 9M14 sales more than doubled (+173.7%) yoy and 4Q14 sales expected to be between RM6-8m.
  • ABI: 3Q14 fell dragged by disappointment in PCB. 4Q14 revenue forecast is estimated to be RM20m while carry forward backlog into 1Q15 will be higher than in 2H14.
  • By summing the mid-points of those guidance, 4Q14 sales could potentially grow 30.4% yoy to RM36.5m.
  • Confident to extend its pioneer status / tax exemptions which will end in 1Q15.
  • Reiterate BUY with unchanged TP of RM3.17, pegged to 1SD above 5-year historical average P/E multiple of 16.2x.
Genting Bhd (BUY çè)
9MFY14: Below Expectations
  • Reported 9MFY14 core PATAMI of RM1.3bn came in below expectations due to weaker-than-expected performance from Genting Singapore .
  • We imputed the latest earnings revision from GenS and GenM and as such, FY14-16 EPS are cut by 12.7%, 2.6% and 4.9% respectively.
  • Post-earnings revisions, TP is cut slightly to RM10.64 (from RM10.81) based on SOP valuations. Maintain BUY.
Genting Malaysia (HOLD çè)
9MFY14 Slightly Below Expectations
  • GenM reported 9MFY14 core PATAMI of RM949.8m came in below expectations from higher-than-expected tax rate.
  • Following the higher-than-expected effective tax rate in 3Q, we increase FY14’s tax rate assumptions. As such, FY14-16 earnings are reduced marginally by 0.4-3.9%.
  • Given that the downgrade in forecasts is for FY14, our TP of RM4.16 is unchanged based on FY15’s SOP valuations. Maintain HOLD.
IOIPG (HOLD ê)
Disappointing 1QFY15
  • Reported 1QFY15 PATAMI of RM101.0m came in below expectations, mainly due to higher-than-expected expenses and effective tax rate.
  • YTD unbilled sales stood at RM1.43bn, representing 0.95x of IOIPG’s FY14 revenue.
  • We trimmed our FY15-17 EPS by approximately 22-25% as we turn more conservative on the group’s prospects.
  • TP is lowered to RM2.65 (from RM3.94) after taking into account earnings revision and higher discount to RNAV of 30% (vs. 20% previously). Our TP of RM2.65 valued IOIPG at 18.5x FY15 P/E, vs. 18.7x FY15 P/E which UEM Sunrise is currently trading at.
  • We also downgraded our recommendation to HOLD in view of persistent earnings disappointment.
Scomi Energy (BUY çè)
2Q Analyst Briefing…
  • Despite declining oil price, drilling campaign from Petronas has picked up with rig count increased from 4 rigs in Jun 14 to 6 rigs in Sep 14 and further increase to 12 rigs in Nov 14.
  • Given this, it expects gross margin for oilfield services to gradually improve from 24% in 2QFY15 to 26% in subsequent quarters.
  • Marine business swung from profit to losses mainly due to lower coal tonnage carried arising from new tax rules imposed by Indonesian government which resulted in production halt of a customer. After the election, it expects the operation to improve.
  • We also understand that national oil companies (NOCs) comprise around 65% of SES’ revenue. NOCs have traditionally been able to better withstand the impact of declining oil price with long term capex plan.
  • We maintained our BUY call with TP reduced from RM1.07 to RM0.93.
Pharmaniaga (BUY çè)
9M14 Results – In Line
  • 9M14 core net profit of RM71.9m, came in within our expectations but slightly ahead of consensus’ estimates, accounting for 77% and 83% of HLIB and consensus full year estimates, respectively.
  • Declared 3rd single tier dividend of 8.0 sen per share (3Q13: 3.0 sen) with ex-date on 5th Dec.
  • 3Q14 revenue gained 13.9% yoy to RM502.1m contributed by the entire core business operations. However, qoq sales contracted 4.4% due to seasonally lower demand.
  • Logistics and Distribution Division posted more than three-fold increase in PBT qoq, boosted by higher ASP coupled with higher sales volume. Manufacturing Division’s PBT slipped due to lower off-take for in-house products from government hospitals as well as higher R&D expenses.
  • Moving forward, Pharmaniaga remains positive as the pharmaceutical sector in Malaysia is showing improved prospects.
  • Reiterate BUY with unchanged fair value of RM5.30 based on FY15 P/E multiple of 14.5x, 10% discount to US peers.
CSC (HOLD çè)
3Q Losses Again
  • Another disappointing quarter. 9MFY14 performance came in weaker than our expectation, with a reported net loss of RM12.3m vs. our full-year net profit forecast of RM5.1m. 
  • YoY. 3QFY14 revenue decreased by 1.2% to RM254.4m and turned into a net loss of RM3.1m from a net profit of RM2.9m, a staggering declining of 206.4%. This is due to lower selling prices.
  • QoQ. 3QFY14 net loss narrowed to RM3.1m (from RM8.8m in the previous quarter) mainly on the back of lower raw material costs.
  • We belief that 4QFY14 looks bleak, thus, we have cut our FY14 forecast to a net loss of RM15.2m. For FY15, we have slashed our earnings by 2.2% and for FY16, we cut by 17.5%.
  • SOP-derived TP lowered by 5.1% to RM1.06 to reflect the roll forward of our base year from FY14 to FY15 (for valuation purpose) and lower earnings forecasts. Maintain HOLD recommendation.
Economics
Managed Float for RON95 & Diesel Report
  • Retail price of RON95 and diesel will be fixed according to a managed float system starting 1 Dec.
  • We are positively surprised as the floating of fuel price will entirely eliminate the government ' s fuel subsidy bill in 2015. Fuel subsidies rose to as high as RM28.9bn in 2013 (13.7% of operating expenditure).
  • The move is favourable to help the government achieving its target fiscal deficit of 3.0% GDP. We see slim chance of the proposed multi-tiered fuel subsidy scheme being implemented. We believe that the government may instead give special BR1M payouts should global crude oil price spikes up sharply in an unexpected manner.
  • We estimate that RON95 and diesel would be retailed at RM2.30/litre and RM2.20/litre respectively in Dec 2014. We maintain our 2014 full-year inflation forecast at 3.2%.
  • Based on our crude oil forecast of US$90/bbl for 2015, we expect RON95 retail price to average RM2.50/litre in 2015. Consequently, our CPI growth forecast for 2015 is raised to 4.3% (previously: 4.0% with multi-tiered fuel subsidy).
  • The managed float fuel scheme is expected to bring greater uncertainty to consumer spending in 2015, which we had already factored in in our projection. We reiterate our projection that GDP growth will moderate to 5.0% in 2015 (2014f: +6.0%).
  • We do not expect the switch to a managed float system for fuel price will alter the thinking of BNM. We maintain our view that BNM will leave its OPR unchanged at 3.25% throughout 2015.
Economics
October Inflation Report
  • Malaysia ' s CPI growth climbed up to 2.8% yoy in October after recording a 12-month low of 2.6% in September, lower than our and market expectations (+3.0%).
  • 20 sen fuel price hike was the sole reason behind the spike in October CPI growth. Price inflation of other components broadly held stable. Food & alcoholic beverages and tobacco witnessed slower price increases.
  • Headline inflation is projected to creep up further in Nov-Dec 14 and 2015, driven by domestic cost factors. We maintain our full-year inflation estimate of 3.2% for 2014 but raise our 2015 forecast to 4.3% (previously: +4.0%) given the commencement of managed float system for fuel prices.
  • We expect BNM to keep the OPR steady at 3.25% throughout 2015, backed by moderate domestic demand, softer global outlook, contained inflation risks and slower property speculative activities.
Traders Brief
Likely to consolidate sideway
  • Last Friday’s black candlestick removed the reversal signal of “Bullish Engulfing” pattern on daily chart, turning KLCI into consolidation mode.
  • The psychological level of 1800 would be a critical support zone after 50% Fibonacci level was penetrated last Friday. Next supports are at 1778 and 1760 if 1800 is broken.
  • However, KLCI could stage a technical rebound during this week, which might be shortlived. Resistances are 1823 (38.2% FR), 1836 (23.6% FR) and 1850 (downtrend line and 200-d SMA).
  • Took profit on ESCERAM last Friday as it hit beyond R1.

Friday, November 21, 2014

HLIB Research Summary - 21 Nov 2014


Automotive (NEUTRAL  çè)
Rebound in Oct, Driven by Perodua
  • Oct TIV rebounded mom to 54.3k units (-1.6% yoy; +13.4% mom) from maiden contribution of Perodua Axia. YTD, TIV was 546.5k units (+0.6% yoy). We expect stronger sales in Nov & Dec, driven by Perodua Axia and Proton Iriz, as well as aggressive campaigns by foreign OEMs.
  • Perodua reported strong sales of 17.7k units (+13.8% yoy; +46.0% mom) due to deliveries of newly launched Axia.
  • Proton sales disappointing at 8.1k units (-37.2% yoy; +1.0%mom), due to mass production hiccups.
  • YTD, Toyota and Nissan sales was relatively weak, behind FY14 sales target, while Honda is on track to achieve its FY14 target.
  • Maintained NEUTRAL on automotive sector with top picks: MBM (TP: RM4.00) and DRB (TP: RM3.00).
SapuraKencana (BUY çè)
Expanding Reserves..
  • SKP announced to acquire three blocks of oil assets from Petronas Carigali in Vietnam with total purchase consideration of US$400m.
  • SKP also awarded PSC for Block SB331 and SB332 onshore Sabah with participating interest of 70%
  • We expect the Vietnam acquisitions to increase 2P oil reserves by 80% to 39mm boe.
  • Assuming net production of 11k bbl/d from Vietnam asset with oil price at US$80/bbl, we estimate it to contribute ~13% to FY01/16 bottomline.
  • Maintain BUY call with an unchanged TP of RM4.26 based on unchanged 16x FY01/16 EPS of 26.6 sen/share.  
RHB Cap (BUY çè)
Growth Traction Gained Momentum
  • 9MFY14 results in line with HLIB and consensus.
  • Strong 3Q on sustained double-digit loans growth, stronger non-interest income (+24% qoq) and wider sequential JAW. 
  • 9MFY14 ROE slightly below KPI but it is not changing as momentum in 3Q to sustain into 4Q, absence of additional provision and lower credit charge vis-à-vis earlier guidance.
  • RHB-OSK integration on track to exceed initial synergy projection.  Coupled with new transformation (IGNITE 2017) progressing well, both has already contributed to the traction in Islamic and non-interest income growth.
  • M&A with CIMB and MBSB to benefit the group and its shareholders.  Dedicated team to deal with integration to ensure BAU momentum is sustained
  • Asset quality continued to improve with comfortable capital ratios.           
  • Target price maintained at RM10.00 or 1.4x merger P/B (vs. RM10.028 merger valuation).  Maintain BUY.
YTLP (SELL ê)
1Q15 Within Expectations
  • Within Expectations - Reported 1QFY06/15 core earnings of RM254.6m, accounting for 27.9% of HLIB and 24.0% of consensus.
  • Main concern on the margin compression for Singapore Seraya Power (due to market overcapacity) and UK Wessex Water (regulatory reform to cut return on WACC).
  • We believe the possibility of concession extension of domestic power plants relatively low.
  • Given the continued earnings risk and lack of catalyst, we downgrade YTLP to SELL (from Hold) with unchanged Target Price of RM1.44, based on 10% discount to SOP.
Bumi Armada (BUY çè)
  • Slightly Below mainly due to slower progress recognition of Kraken and Angola projects.
  • Currently, Bumi is targeting 3 major FPSO bids in Ghana , Nigeria and Namibia and expects the result of tenders to be known by 1QFY15.
  • FY14 earnings adjusted downward by 7% to reflect slower earnings recognition for Kraken and Angola projects under finance lease and lower margin for T&I.
  • We maintain our BUY call with TP reduced from RM2.06 to RM1.74 based on SOP valuation method following adjustment to the group net debt position and lower value from T&I segment.
Genting Plantations (HOLD çè)
Within our expectation
  • 9MFY14 core net profit of RM235m (+21.9%) came in within our expectation, accounted for 75.7% of our full-year forecast.
  • We nudged up our FY15-16 net profit forecasts by 2.1-2.5%, largely to account for earnings contribution from the biodiesel production.
  • SOP-derived TP raised by 10.4% to RM10.50 to reflect higher net profit forecasts and its latest net cash position. Maintain HOLD recommendation.  
Aeon (HOLD çè)
3QFY14: Well below expectations
  • Below expectations – Aeon’s revenue of RM2733.8m (+6% yoy) translated into core earnings of RM123.3m (excluding RM14.2m exceptional gain occurred in previous quarter) came in well below our expectations, accounting for 53% of ours and 52% of streets’ full year estimates.
  • YTD core net profit was depressed by 21% yoy, largely due to (1) higher utilities costs resulting from the electricity tariff hike; (2) greater initial start-up costs from the opening of new stores; (3) Aeon’s 30th anniversary promotional costs; and (4) higher marketing costs that was needed to boost consumer spending.
  • Cut FY14, FY15, FY16 earnings by 25%, 12% and 10%, respectively, to reflect the short term macro headwinds, weak business and consumer sentiment as well as higher than expected operating costs.
  • As a result, TP slashed by ~12% to RM3.42 pegged to unchanged 21.9x P/E FY15 EPS of 15.6 sen, based on 1 SD above 3-year historical average. Maintain HOLD.
Mah Sing (BUY çè)
9MFY14 Results & Corporate Exercises
  • MSGB’s 9MFY14 PATAMI of RM254.7m came in within expectations.
  • MSGB achieved property sales of circa RM2.45bn YTD. It has also grown its landbank by 1,134 acres, bringing the group’s undeveloped land bank to 3,658 acres with GDV of RM44.8bn. Unbilled sales stood at an outstanding RM5.1bn, representing 2.94x of FY13 property revenue.
  • MSGB also proposed (1) renounceable rights issue with free detachable warrants to raise up to RM630m; and (2) a 1 for 4 bonus issue following the rights issue.
  • Based on the indicative scenario of 3 rights for every 10 MSGB shares, there will be a total of 442.7m rights issued. This will result in dilution of FY14-15 EPS by 16.6% and 1101% while RNAV will be diluted by 13.8%.
  • However, this is expected to be mitigated by the potential earnings from the launch of the development in Puchong (1HFY15) and Seremban (2HFY15).
  • Gearing will be lowered significantly to 0.13x from 0.37x, allowing more room to gear up. The expected completion for the proposed rights issue with free warrants and bonus issue are by 1QFY15 and 3QFY15, respectively.
  • BUY recommendation and TP of RM2.90 remained unchanged.
Kossan (HOLD é)
9M14 Results
  • 9M14 core net profit accounted for 65.5% and 61.2% of HLIB and consensus full year estimates, respectively.
  • We deem this to be in line as we are expecting a stronger quarter ahead from the contribution of new capacity.
  • Declared 1st interim dividend of 3.5 sen per share (9M13: 3.5 sen).
  • QoQ: 3Q14 revenue grew (+8.1%) on the back of stronger sales from gloves and clean-room divisions, despite slower sales from TRP division, translating into higher core earnings (+7.4%).
  • YoY: 9M14 revenue contracted (-4.5%) due to lower ASP in gloves division, offsetting the higher sales in clean-room division. Earnings turned positive thanks to improved margin.
  • Upgrade from SELL to HOLD as we roll forward our valuation to CY16, leading to a higher TP of RM4.49.
  • Our valuation is pegged to 12.8x of CY16 EPS, based on 1SD above 5-year historical average P/E.
PosM (SELL ê)
Weak 2Q15; Dragged by Mail and Retail
  • Below - Reported 2QFY03/15 core earnings of RM8.2m and 1HFY03/15 of RM37.2m, which is 27.1% of HLIB and 22.9% of consensus.
  • The weak performance was mainly due to higher than expected cost structures (related to staff and transportations).
  • Recognized gain of RM25.5m from expired postal order in 2Q15.
  • Cut earnings by 25-36% for FY03/15-17, after adjusting for the higher than expected cost structures.
  • Downgrade PosM to SELL (from Hold) with lower Target Price of RM3.65 (from RM4.60), based on 18x P/E for FY03/16.
Scomi Energy (BUY çè)
Drag by marine segment.
  • Below expectations due to lower margin as a result of change in product mix coupled with losses from marine segment.
  • Marine segment under pressure with PAT swung from profit to losses. This was mainly due to lower utilisation of vessels and volume coal transported.
  • We understand the company is still looking for opportunity in RSCs, brownfield and EOR businesses in the near future.
  • We maintained our BUY call with a TP of RM1.07 (pending review of earnings forecasts).
CBIP (HOLD çè)
Within expectations
  • 9MFY14 reported net profit of RM67m (+12.6%) accounted for 69.4% and 67.9% of our and consensus full-year forecasts. We consider the results within expectations, as we expect stronger 4Q (the special purpose vehicle division is seasonally stronger in 4Q). 
  • Proposed a 2nd interim DPS of 3 sen, bringing total DPS YTD to 5.5 sen.
  • Maintain earnings forecasts, TP of RM2.13, as well as HOLD recommendation.  
ViTrox (BUY çè)
9M14 Results – Exceed Expectations
  • 9M14 core net profit of RM35.4m was higher-than-expected, accounted for 84.6% of HLIB full year estimate.
  • The sequential slowdown is very much guided and expected mainly due to industry’s seasonality. Even so, 3Q14 revenue of RM39.5m is another remarkable milestone as the second highest quarterly sales in its history.
  • Gartner expects global semiconductor capital spending to be robust in 2015, growing 11.3% yoy to reach USD43.6bn.
  • China’s enormous investment (Rmb1tr) into semiconductor industry may lead to potential multi-year high demand of ViTrox’s products.
  • Reiterate BUY with unchanged TP of RM3.17, pegged to 1SD above 5-year historical average P/E multiple of 16.2x.
Traders Brief
Follow-through rebound still intact to retest 1836-1850 resistance zones
  • The follow-through rebound remained intact as reversal pattern of “Bullish Engulfing” on 17 and 18 Nov is still in force and the traditional year-end Nov/Dec window dressing activities would spur some positive impacts. Further upside targets are 1836 (23.6% FR) and 1850 (downtrend line and 200- SMA) and 1860.
  • However, near-term outlook for KLIC is not out of the woods yet since downtrend line has not been taken out yet. Thus, KLCI will continue to trap in range bound consolidation mode within 1800-1850, unless the 1850 resistance is taken out decisively.
  • Short term supports are 1812 (50% FR) and 1800
  • Took profit on PENTA yesterday as it hit R1.
  • Today’s recommendation: Impulse Trading BUY on ESCERAM.
Impulse Trading - ESCERAM
ESCERAM: Resumption of uptrend on the card
  • Share price movement has caught our attention as Downtrend Channel and Flag pattern on hourly and daily chart respectively have been taken out by a bullish candlestick, inducing sign of resumption of its uptrend.
  • Our target price projection is pegged at RM0.255, RM0.27 and RM0.29. However, always prepared to set cut loss if situation changes. Support at RM0.23 with cut loss below RM0.22.

Friday, October 3, 2014

HLIB Research Summary - 3 Oct 2014

ViTrox: The Rmb1 Trillion “Quan Xi”
  • China is entering into the semiconductor era to fuel its economy growth. A task force was convened to develop a policy framework that is targeting a CAGR for the industry of 20% between 2015 and 2020, with potential financial support from the government of up to Rmb1tr (USD170bn) over the next 5 to 10 years.
  • We think this will be a boon to ViTrox as a semiconductor equipment supplier leading to potential multi-year high demand of its products.
  • With its cutting edge precision technology, we are confident that ViTrox has the upper hand over competitions and can win more market share, especially when 20nm and below chips are becoming an industry norm.
  • Its presence is well-established and has been increasing both sales channel partners and customers in China .
  • Upgrade from HOLD to BUY after raising our fair value to RM3.17, pegged to 1SD above 5-year historical average P/E multiple of 16.2x.
Traders Brief: Continued weakness unless staging a decisive breakout above 200-d SMA
  • Ahead of the key U.S. jobs data tonight and disappointment on ECB’s meeting outcome coupled with the surprised 20sen petrol hike effective yesterday, investors sentiment will remain muted ahead of the widely-anticipated Budget 2015 to be tabled on 10 Oct.
  • Given the failure to stage a breakout above the immediate resistance of 200-d SMA in the last few sessions, the odds would favour weaker trend ahead, targeting 1800-1820 zones if the 6-month low of 1829 support cannot hold.
  • On the upside, the 200-day SMA at 1852 may continue to act as resistance in the immediate term, with higher targets at 1858 (30-d SMA) and 1867 (23.6% FR)
  • Today, we have a write-up on regional bourses technical outlook; kindly refer to our separate report (Trading Idea – Regional Bourses Technical Outlook).
Trading Idea: Overview of Regional Market Technical Outlook 
  • Technically, most of the regional market technical outlooks (except for SHCOMP) are still showing weaknesses ahead as their corrections are still intact coupled with negative technical indicators.

Wednesday, August 27, 2014

Research Summary: 25 August 2014

Research Summary: 25 August 2014

Research House
Type
Company/Sector
Report Title
Rating/Call
Target
RHB
Company update
WCT
Improved “visibility” for new jobs
Neutral
RM2.31
RHB
Results review
MayBulk
A weak quarter as rates at depressed level
Buy
RM2.00
RHB
Results review
Karex
Grand finale
Buy
RM3.41
RHB
Results review
Daya
Going full steam ahead
Neutral
RM0.35
RHB
Results review
Tan Chong
Freshly squeezed and battered
Sell
RM4.30
RHB
Results review
Time dotCom
A more cautious tone
Neutral
RM5.20
RHB
Results review
AMMB
Lifted by gains from sale of stakes in insurance units
Buy
RM8.00
RHB
Results review
MRCB
Earnings boosted by gains from DUKE’s disposal
Buy
RM2.05
RHB
Results review
Dayang
Going full steam ahead
Buy
RM4.80
RHB
Briefing
GAB
Another challenging year ahead
Neutral
RM13.10
CIMB
Sector
Plantations
The CPO price conundrum
Neutral
 
CIMB
Results note
Karex
Good FY14 results
Add
RM3.38
CIMB
Flash note
GAB
More challenges ahead
Reduce
RM12.00
CIMB
Results note
AMMB
Cash in on divestment gains
Hold
RM7.10
CIMB
Sector
Banks
Ruled by negative sentiment
Underweight
 
CIMB
Results note
MRCB
Driven by gains from DUKE
Add
RM2.08
CIMB
Flash note
SapuraKencana Petroleum
All gassed up and everywhere to go
Add
RM7.00
CIMB
Results note
Tan Chong
Braking hard due to competition
Hold
RM5.26
CIMB
Results note
Thong Guan
Moving up the value chain
Add
RM3.95
CIMB
Results note
TH Heavy Engineering
A lightweight 1H
Add
RM1.23
CIMB
Eco update
Economic
Jun LI: Chugging along
 
 
CIMB
Flash note
WCT
Good enough to get by
Hold
RM2.32
Maybank
Results review
AMMB
A weak start to the financial year
Hold
RM7.70
Maybank
Results review
Tan Chong
Disheartening 1H14; cut to sell
Sell
RM4.00
Maybank
Results review
Time dotCom
Back on track
Hold
RM5.00
Maybank
Special Feature
IFCA MSC
At the cusp of a significant rerating
Not rated
RM0.42
Maybank
Briefing
WCT
When the going gets tougher…
Hold
RM2.30
Maybank
Company update
UMW
Wins MYR200m Myanmar contract
Buy
RM13.82
Maybank
Company update
GAB
Still a cloudy outlook
Hold
RM13.20
Maybank
Technical
OKA
 
Short-term buy
 
Kenanga
Sector update
Plantation
Imputing Indonesia foreign ownership limit risk
Neutral
 
Kenanga
Results note
MRCB
Going as planned
Outperform
RM2.48
Kenanga
Company update
GAB
Banking on innovation and efficiency
Underperform
RM12.93
Kenanga
Results note
AMMB
Subdued quarter
Market perform
RM7.02
Kenanga
Quick bites
UMW
Headway in Myanmar
Market perform
RM13.93
Kenanga
Company update
WCT
Facing challenging times
Market perform
RM2.21
Kenanga
Results note
Thong Guan
2Q14 results within expectations
Outperform
RM3.70
Kenanga
Results note
Tan Chong
Below expectations
Underperform
RM4.62
Kenanga
Results note
Pestech
2Q14 on track
Outperform
RM4.36
Kenanga
Results note
MayBulk
1H14 within expectations
Outperform
RM2.53
Kenanga
Results note
Dayang
A quiet 2Q14 but firm FY15 prospects
Outperform
RM4.82
HL
Eco insight
Economic
Weak CPO price: lower CA surplus?
 
 
HL
Results review
Time dotCom
1H14 results in line
Hold
RM5.09
HL
Results review
MRCB
2Q results: swung back to losses
Buy
RM1.97
HL
Results review
Dayang
Margin improving…
Buy
RM4.07
HL
Results review
Tan Chong
Further margin deterioration
Sell
RM4.00
HL
Newsbreak
SapuraKencana Petroleum
Makes big gas discovery
Buy
RM5.52
HL
Briefing
Vitrox
Another quantum leap year
Hold
RM2.95
HL
Company insight
Scomi Energy
Multiple growth drivers ahead….
Buy
RM1.23
HL
Briefing
WCT
Expecting a quiet year
Hold
RM2.26
HL
Sector
Plantations
Bleak near-term outlook
Underweight
 
HL
Briefing
GAB
Innovation’s the next engine of growth
Hold
RM14.39
HL
Results review
AMMB
Weak results boosted by profit from sale
Hold
RM7.77